ZEALAND PHARMA A/S: Financial statements 2017
CVR: 20045078
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ZEALAND PHARMA A/S (CVR 20045078) has filed annual accounts for 2017. In 2017, the company reported revenue of DKK 139,775,000 and a net result of DKK -272,271,000 compared with DKK -153,910,000 the year before. That is a decrease of 40.5% compared with the year before. The profit margin was -194.8%. Equity in the 2017 report amounted to DKK 528,468,000. The solvency ratio was 71.7%.
- Revenue
- DKK 139,775,000
- Profit/Loss
- DKK -272,271,000
- Equity
- DKK 528,468,000
- Total Assets
- DKK 737,238,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | 139.8M | - | -272.3M | 528.5M | - |
| 2016 | 234.8M | - | -153.9M | 278.2M | - |
| 2015 | 187.7M | 165.4M | -114M | 252.2M | - |
| 2014 | 153.8M | 140M | -65M | 252.8M | - |
Official annual report
Keep an eye on ZEALAND PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of December 1, 2017, Helle Haxgart has joined the board of directors of ZEALAND PHARMA A/S.
As of December 1, 2017, Rasmus Just has left the board of directors of ZEALAND PHARMA A/S.
As of November 30, 2017, Helle Haxgart has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2017 to September 30, 2017.
As of August 31, 2017, Helle Størum has left the board of directors of ZEALAND PHARMA A/S.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2017 to June 30, 2017.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2017 to March 31, 2017.
ZEALAND PHARMA A/S has published its annual report for 2016. Revenue came to DKK 234,778,000, and the net result was DKK -153,910,000.
ZEALAND PHARMA A/S has published its interim report for the period January 1, 2016 to June 30, 2016.
About ZEALAND PHARMA A/S
ZEALAND PHARMA A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1997. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named ZEALAND PHARMACEUTICALS A/S and PEPTIDE PROBE TECHNOLOGIES ApS. The management consists of Adam Sinding Steensberg and Henriette Wennicke. The board consists of Alf Gunnar Martin Nicklasson (chair), Kirsten Aarup Drejer, Adam Krisko Nygaard and Anneline Nansen. The company's owners include ZEALAND PHARMA A/S, Van Herk Investments B.V. and Van Herk Management Services B.V.. The company has 575 employees (2026). In 2025, the company reported revenue of DKK 9,214,860,000 and a net result of DKK 6,455,008,000 compared with DKK -1,078,828,000 the year before. Equity in the 2025 report amounted to DKK 14,830,613,000.